NCT04124549

Brief Summary

Hemodialysis (HD) is an important and commonly used renal replacement therapy (RRT) for End-Stage Renal Disease (ESRD) patients worldwide. Inadequate HD, impaired exercise capacity and declined peripheral muscular strength resulted by HD and ESRD are still disturbing problems, which also predicts poor renal prognosis and poor quality of life. The results of systematic reviews by the investigators have shown that aerobic exercise and combined exercise can improve dialysis efficacy (alleviate uremia symptoms), improve aerobic exercise capacity and muscle strength, and improve patients' quality of life, which also supports the notion that the National Kidney Foundation Disease Outcomes Quality Initiative (K/DOQI) recommends exercise as cornerstone of ESRD rehabilitation. Therefore, this study used the effective exercise type of the systematic review results - combined exercise as an intervention method to observe its effects on dialysis efficacy, blood pressure, aerobic exercise capacity, muscle strength and quality of life. The study hypothesized that combined exercise can not only improve dialysis efficacy, but also has an interaction effect with intervention duration, which deserves researches' attention. Combined exercise will also improve blood pressure (including systolic blood pressure and diastolic blood pressure) in patients with ESRD and reduce the symptoms of renal hypertension. It will also improve the exercise capacity and muscle strength of ESRD patients and improve their quality of life.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
44

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Mar 2019

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

March 11, 2019

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 17, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 17, 2019

Completed
8 days until next milestone

First Submitted

Initial submission to the registry

September 25, 2019

Completed
16 days until next milestone

First Posted

Study publicly available on registry

October 11, 2019

Completed
Last Updated

November 26, 2019

Status Verified

November 1, 2019

Enrollment Period

6 months

First QC Date

September 25, 2019

Last Update Submit

November 22, 2019

Conditions

Keywords

End-Stage Renal DiseaseExerciseDialysis EfficacyPhysical Fitness

Outcome Measures

Primary Outcomes (2)

  • Dialysis Efficacy (sp Kt/V)

    Sp Kt/V is a dimensionless, mathematical representation of serum urea clearance, monitored by On-Line Clearance Monitor (OCM)-equipped Fresenius 4008-S machines (Fresenius, Bad Homburg, Germany).

    sp Kt/V was measured at baseline (before intervention) and after 24 weeks of intervention.

  • Dialysis Efficacy (sp Kt/V)

    Sp Kt/V is a dimensionless, mathematical representation of serum urea clearance, monitored by On-Line Clearance Monitor (OCM)-equipped Fresenius 4008-S machines (Fresenius, Bad Homburg, Germany).

    sp Kt/V was measured after 4, 8, 12, 16 and 20 weeks of intervention for observing the effects of intervention and time on sp Kt/V more accurately.

Secondary Outcomes (5)

  • Blood Pressure (including systolic blood pressure (SBP) and diastolic blood pressure (DBP))

    BP was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.

  • Six-minute walk test (6MWT)

    6MWT was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.

  • 5-repetition sit-to-stand test (STS 5)

    The STS-5 was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.

  • 30-second sit-to-stand test (STS 30)

    The STS-30 was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.

  • Kidney Disease Quality of Life (KDQOL-36)

    The KDQOL-36TM was measured at baseline (before intervention), 12 weeks after intervention and 24 weeks after intervention.

Study Arms (2)

Stand of Care

SHAM COMPARATOR

Patients in the control group received usual care with sham exercise.

Other: Usual care with sham intervention

Combined Exercise

EXPERIMENTAL

The intervention was a 24-week progressive intradialytic combined cycling exercise which proceed in the first HD 2 hours. Each exercise lasted about 40 minutes.

Other: Intradialytic Combined Exercise

Interventions

Patients in the control group received usual care and were advised to do sham exercise such as stretch legs and arms about 15 minutes during the first 2 HD hours.

Stand of Care

Each session consisted of a 5-minute warm-up, cool-down and 30-minute cycling at a Rating of Perceived Exertion (RPE) of 12-14. The machine has two exercise types including aerobic exercise and resistance exercise. Patients were asked to perform aerobic exercise 20-min and resistance exercise 10-min in the first stage. Every four weeks is divided into a stage. And the time of aerobic exercise and resistance exercise were personally adjusted per stage to maintain the personalized target RPE. In the following stages, aerobic exercise was continued 15-min for the second stage, 10-min for the third and the forth stage, 15-min for the fifth stage and 20-min for the last stage. And the time for resistance exercise was adjusted for the total exercise time. The resistance of exercise also progressive increased in order to adapt the target RPE. It was accessible to patients of different ages, gender, cultures and ethnicities.

Combined Exercise

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adult (age≥18) with stable ESRD.
  • Receiving≥3 months HD.
  • HD 3 times per week.
  • Volunteer for participating this trial.

You may not qualify if:

  • Unable to exercise (severe musculoskeletal pain at rest or with minimal activity precluding walking or stationary cycling; unable to sit, stand or walk unassisted) (walking device such as cane or walker allowed).
  • Had shortness of breath at rest or with activities of daily living (NYHA Class IV).
  • Had mental disease, disturbance of consciousness and couldn't cooperate with investigations and exercise.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The First Affiliated Hospital of Xi'an Jiaotong University

Xi'an, Shaanxi, 710000, China

Location

MeSH Terms

Conditions

Kidney Failure, ChronicMotor Activity

Condition Hierarchy (Ancestors)

Renal Insufficiency, ChronicRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Aili Lv, Doctor

    Xi'an Jiaotong University Health Science Center

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Patients in the HD centers were randomly assigned to one of two wards at the time that they began to HD in this center. And in order to avoid contamination, randomization in this study was in accordance with the centers to which patients were assigned. Every HD center was randomized to either continue on usual HD care (control group) or intervention of intradialytic combined exercise based on usual HD care (intervention group).
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
student

Study Record Dates

First Submitted

September 25, 2019

First Posted

October 11, 2019

Study Start

March 11, 2019

Primary Completion

September 17, 2019

Study Completion

September 17, 2019

Last Updated

November 26, 2019

Record last verified: 2019-11

Data Sharing

IPD Sharing
Will not share

Locations